title: Breast Cancer Survivorship: Where Are We Today?
abstract: Breast cancer is the most common cancer in women, and survivors with this diagnosis account for almost one fourth of the over 14 million cancer survivors in the US. After several decades of basic and clinical trials research, we have learned much about the heterogeneity of breast cancer and have evolved a complex and multidisciplinary treatment approach to the disease. Increasingly, we are paying attention to the long term and late effects of breast cancer treatment, and this is largely the subject of this volume. In this chapter, the authors introduce the topic of breast cancer survivorship and highlight the organization and content of this volume, briefly describing the contents of the subsequent chapters.
authors.affiliation: UCLA Schools of Medicine and Public Health, Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA, pganz@mednet.ucla.edu.
authors.forename: Patricia A
authors.initials: PA
authors.lastname: Ganz
authors.forename: Pamela J
authors.initials: PJ
authors.lastname: Goodwin
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics / Q000401:mortality* / Q000523:psychology / Q000628:therapy; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D011788:Quality of Life; D015996:Survival Rate; D017741:Survivors / Q000523:psychology / Q000706:statistics & numerical data; D013577:Syndrome; D016896:Treatment Outcome